Anzeige
Meldung des Tages: Double Mer Projekt: SAGA zweites strategisches Standbein – Uran für das KI-Zeitalter

Penumbra Aktie News

Aktie
WKN:  A14Y65 ISIN:  US70975L1070 US-Symbol:  PEN Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
359,26 $
+0,73 $
+0,20%
303,72 € 23.01.26
Depot/Watchlist
Marktkapitalisierung *
10,43 Mrd. €
Streubesitz
-
KGV
659,67
neu: Nachhaltigkeits-Score
42 %
Index-Zuordnung
-

Penumbra News

21.01.26 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS PR Newswire
21.01.26 - PR Newswire
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights PR Newswire
16.01.26 - PR Newswire
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN PR Newswire
15.01.26 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN) PR Newswire
15.01.26 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire
15.01.26 - PR Newswire
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results
Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results PR Newswire
15.01.26 - PR Newswire
Boston Scientific announces agreement to acquire Penumbra, Inc.
Boston Scientific announces agreement to acquire Penumbra, Inc. PR Newswire
29.12.25 - PR Newswire
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
19.11.25 - PR Newswire
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference PR Newswire
05.11.25 - PR Newswire
Penumbra, Inc. Reports Third Quarter 2025 Financial Results
Penumbra, Inc. Reports Third Quarter 2025 Financial Results PR Newswire
03.11.25 - PR Newswire
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with ...
27.10.25 - PR Newswire
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment ...
08.10.25 - PR Newswire
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025 ...
09.09.25 - PR Newswire
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile PR Newswire
27.08.25 - PR Newswire
Penumbra, Inc. Names Shruthi Narayan as Company President
Penumbra, Inc. Names Shruthi Narayan as Company President PR Newswire
20.08.25 - PR Newswire
Penumbra, Inc. to Present at Upcoming Investor Conferences
Penumbra, Inc. to Present at Upcoming Investor Conferences PR Newswire
30.07.25 - PR Newswire
Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference
Penumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference PR Newswire
29.07.25 - PR Newswire
Penumbra, Inc. Reports Second Quarter 2025 Financial Results
Penumbra, Inc. Reports Second Quarter 2025 Financial Results PR Newswire
01.07.25 - PR Newswire
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025
Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025 PR Newswire
16.06.25 - PR Newswire
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial PR Newswire

Newssuche

Videos

newspaper
22.01.26 -5,56%
Trading Insights vom 22.01.26
Preisschock bei Erdgas! Was sind die Gründe, wie geht man damit um? Gold auf neuem Allzeithoch: wie ... Mehr »